Dosentrx Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Not Applicable
Recruiting
- Conditions
- Any Solid Oral Medication
- Interventions
- Device: Use of ReX to dispense and monitor solid oral medication therapy.
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Dosentrx Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT06344416
- Locations
- 🇺🇸
Allina, Minneapolis, Minnesota, United States
🇺🇸Texas Oncology, Austin, Texas, United States
🇺🇸Virginia Cancer Center, Richmond, Virginia, United States
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.
Recruiting
- Conditions
- Any Solid Oral Medication
- Interventions
- Device: Use of ReX to dispense and monitor solid oral medication therapy.
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Dosentrx Ltd.
- Target Recruit Count
- 1000
- Registration Number
- NCT06335758
- Locations
- 🇺🇸
OHC, Cincinnati, Ohio, United States
Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).
Not Applicable
- Conditions
- Adherence, MedicationCystic Fibrosis
- Interventions
- Device: ReX-C system
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Dosentrx Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT04215796
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Select One, Israel
🇮🇱Carmel Medical Center, Haifa, Israel
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
Not Applicable
Suspended
- Conditions
- Side EffectOncologyAdherence, Medication
- Interventions
- Device: ReX-C system
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2021-09-20
- Lead Sponsor
- Dosentrx Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04091711
- Locations
- 🇮🇱
Oncology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence.
Not Applicable
Recruiting
- Conditions
- Thromboembolism
- Interventions
- Device: ReX-C interventionOther: Standard of Care
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Dosentrx Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT03424330
- Locations
- 🇮🇱
Carmel Medical Center, Haifa, Israel
Evaluation of Oral PCA Device - PCoAâ„¢ Acute
Not Applicable
Completed
- Conditions
- Pain, Postoperative
- Interventions
- Device: patients receiving oral analgesics via the PCoAâ„¢ Acute
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Dosentrx Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT03134001
© Copyright 2025. All Rights Reserved by MedPath